Medical News Today: Leafy greens may contribute to a healthy heart
In a first-of-its-kind study, researchers examine the link between vitamin K and the structure and good functioning of the heart in teenagers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 6, 2017 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news
Too Little Vitamin K Could Harm Young Hearts
WEDNESDAY, Oct. 4, 2017 -- Bypassing leafy green veggies could take a toll on teens ' heart health, new research suggests.
Teens who ate the least vitamin K-rich foods -- such as spinach, cabbage, iceberg lettuce and olive oil -- had triple the risk... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2017 Category: General Medicine Source Type: news
Non-Vitamin-K Oral Anticoagulants Linked to Major Bleeds via Drug Interactions (FREE)
By Joe Elia
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Non-vitamin-K oral anticoagulants (NOACs) are associated with major bleeding episodes caused by drug-drug interactions, a Taiwanese study finds. The authors note … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 4, 2017 Category: Primary Care Source Type: news
Scientists have found another reason for children to eat their green leafy vegetables
(Medical College of Georgia at Augusta University) A study of 766 otherwise healthy adolescents showed that those who consumed the least vitamin K1-- found in spinach, cabbage, iceberg lettuce and olive oil -- were at 3.3 times greater risk for an unhealthy enlargement of the major pumping chamber of their heart, according to the study published in The Journal of Nutrition. Vitamin K1, or phylloquinone, is the predominant form of vitamin K in the U.S. diet. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 2, 2017 Category: Biology Source Type: news
CYP2C9 Variants Linked to Clinical Events in VTE
Risk of any clinical event, death, non - major bleeding up for seniors treated with vitamin K antagonists (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 5, 2017 Category: Cancer & Oncology Tags: Internal Medicine, Emergency Medicine, Oncology, Pathology, Pharmacy, Pulmonology, Geriatrics, Journal, Source Type: news
Reversal Strategies for Non-vitamin K Antagonist OACs Reversal Strategies for Non-vitamin K Antagonist OACs
What are the current best options for the reversal of the effects of NOACs due to an emergency situation?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 11, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Stroke warning: Taking THIS vitamin could put you at risk of a blood clot
STROKES can occur when a blood clot blocks the flow of blood through a blood vessel. Those at risk are usually prescribed anticoagulants - however taking vitamin K can interfere with how well they work. (Source: Daily Express - Health)
Source: Daily Express - Health - August 9, 2017 Category: Consumer Health News Source Type: news
Bayer ’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent Placement (for specialized target groups only)
Positive CHMP Opinion is based on data from the Phase IIIb PIONEER AF-PCI study, which demonstrated significantly reduced rates of clinically significant bleeding with Xarelto compared with VKA in patients with non-valvular atrial fibrillation (AF) who require oral anticoagulation and are also receiving antiplatelet therapy after percutaneous coronary intervention (PCI) with stent placement (1) / PIONEER AF-PCI is the first and currently only randomised clinical trial of a non-vitamin K antagonist oral anticoagulant (NOAC) in this patient population / Final decision of European Commission expected by the end of this year (...
Source: Bayer Company News - July 21, 2017 Category: Pharmaceuticals Source Type: news
21.07.17: Not intended for U.S. and UK Media
Bayer's Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent PlacementPositive CHMP Opinion is based on data from the Phase IIIb PIONEER AF-PCI study, which demonstrated significantly reduced rates of clinically significant bleeding with Xarelto compared with VKA in patients with non-valvular atrial fibrillation (AF) who require oral anticoagulation and are also receiving antiplatelet therapy after percutaneous coronary intervention (PCI) with stent...
Source: Bayer IR Newsfeed: Events - July 20, 2017 Category: Pharmaceuticals Source Type: news
Anticoagulants for Pregnant Women With Mechanical Heart Valves Anticoagulants for Pregnant Women With Mechanical Heart Valves
While vitamin-K antagonists are usually used to treat patients with mechanical heart valves, they are teratogenic. Can they be used safely in pregnancy, and are there better alternatives?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
NOAC Dosing in Patients With AF and Renal Dysfunction NOAC Dosing in Patients With AF and Renal Dysfunction
How should dosing of the non-vitamin K antagonist oral anticoagulants be adjusted in AF patients with impaired renal function?Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 10, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Dairy products a good dietary source of some types of vitamin K
(Tufts University, Health Sciences Campus) A new study finds that US dairy products are a significant source of the MK form of vitamin K and indicates that MK forms of the nutrient are more present in commonly-consumed foods than previously thought. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 2, 2017 Category: International Medicine & Public Health Source Type: news
Atrial Fibrillation Patients With Type 2 Diabetes Benefit From Non –Vitamin K Oral Anticoagulants
After a review of the epidemiology and pathophysiology of the connections between atrial fibrillation (AF) and type 2 diabetes, a team of researchers led by Anna Plitt, MD, of Mount Sinai Hospital, has concluded that many high-risk patients with both conditions may benefit from treatment with non-vitamin K antagonist oral anticoagulants (NOACs). (Source: Caring for the Ages)
Source: Caring for the Ages - June 1, 2017 Category: Health Management Authors: Jason Harris Source Type: news
08.02.17: Not intended for U.S. and UK Media
Phase III COMPASS study with Bayer's Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early Coronary or peripheral artery disease patients carry significant risk of fatal or debilitating myocardial infarction and stroke / Rivaroxaban is the only non-vitamin K antagonist oral anticoagulant currently under assessment in this high risk patient populationmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 7, 2017 Category: Pharmaceuticals Source Type: news
Study appears first in the nation to examine the impact of vitamin K supplements on the cardiovascul
(Medical College of Georgia at Augusta University) Researchers want to know whether a vitamin K supplement is an effective, inexpensive way to help reduce the cardiovascular risk of obese children. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 31, 2016 Category: Biology Source Type: news
